Elizabeth Miller

Navedeno

	Vse	Od leta 2020
Navedbe	44766	8794
indeks h	106	48
indeks i10	373	187

2300

1150

575

1725

199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025111 139 117 129 143 224 262 252 402 412 589 817 920 1056 1230 1280 1649 1427 1307 1380 1653 1980 2061 2181 2226 2250 2141 1980 2258 2113 1955 2115 1626 1502 1338 253

Javni dostop

Prikaži vse

67 člankov

3 članki

na voljo

ni na voljo

Na podlagi zahtev v povezavi s financiranjem

Soavtorji

Nick AndrewsUK Health Security AgencyPreverjeni e-poštni naslov na ukhsa.gov.uk
David GoldblattProfessor of Vaccinology and ImmunologyPreverjeni e-poštni naslov na ucl.ac.uk
Julia StoweUK Health Security AgencyPreverjeni e-poštni naslov na phe.gov.uk
Mary RamsayPreverjeni e-poštni naslov na hpa.org.uk
Paddy FarringtonOpen University (Retired)Preverjeni e-poštni naslov na open.ac.uk
John EdmundsProfessor of Infectious Disease Modelling, London School of Hygiene and Tropical MedicinePreverjeni e-poštni naslov na lshtm.ac.uk
Shamez LadhaniImmunisation Department, Public Health EnglandPreverjeni e-poštni naslov na phe.gov.uk
Richard PebodyUKHSAPreverjeni e-poštni naslov na ukhsa.gov.uk
Albert Jan van HoekHealth economist / Infectious disease modeller, RIVMPreverjeni e-poštni naslov na rivm.nl
Caroline TrotterUniversity of CambridgePreverjeni e-poštni naslov na cam.ac.uk
Peter RichmondAssociate Professor, Division of Paediatrics, University of Western AustraliaPreverjeni e-poštni naslov na uwa.edu.au
Norman Kenneth FryLaboratory Surveillance Lead – Vaccine Preventable Bacteria; UK Health Security AgencyPreverjeni e-poštni naslov na ukhsa.gov.uk
Professor Maria ZambonPublic Health EnglandPreverjeni e-poštni naslov na phe.gov.uk
Stefan FlascheCharite Berlin & LSHTMPreverjeni e-poštni naslov na charite.de
Professor Sir Andrew PollardUniversity of OxfordPreverjeni e-poštni naslov na paediatrics.ox.ac.uk
Mark JitProfessor and Chair, Dept of Global and Environmental Health, New York UniversityPreverjeni e-poštni naslov na nyu.edu
Alessia MelegaroProfessor of Demography and Social Statistics, Bocconi UniversityPreverjeni e-poštni naslov na unibocconi.it
Yoon Hong ChoiUK Health Security AgencyPreverjeni e-poštni naslov na ukhsa.gov.uk
Marc BaguelinSenior Lecturer, Imperial College London - Assoc. Prof London School of Hygiene & Tropical MedicinePreverjeni e-poštni naslov na imperial.ac.uk
Pia HardelidUniverity College LondonPreverjeni e-poštni naslov na ucl.ac.uk

Spremljaj

Elizabeth Miller

Professor

Preverjeni e-poštni naslov na lshtm.ac.uk

Vaccines


Naslov Razvrsti po navedbah Razvrsti po letniku Razvrsti po naslovu	Navedeno Navedeno	Leto
Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association B Taylor, E Miller, CP Farrington, MC Petropoulos, I Favot-Mayaud, J Li, ... The Lancet 353 (9169), 2026-2029, 1999	1285	1999
Impact of anti-vaccine movements on pertussis control: the untold story EJ Gangarosa, AM Galazka, CR Wolfe, LM Phillips, E Miller, RT Chen, ... The Lancet 351 (9099), 356-361, 1998	991	1998
Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study E Miller, K Hoschler, P Hardelid, E Stanford, N Andrews, M Zambon The Lancet 375 (9720), 1100-1108, 2010	891	2010
Effectiveness of maternal pertussis vaccination in England: an observational study G Amirthalingam, N Andrews, H Campbell, S Ribeiro, E Kara, K Donegan, ... The Lancet 384 (9953), 1521-1528, 2014	874	2014
Consequences of confirmed maternal rubella at successive stages of pregnancy E Miller, JE Cradock-Watson, TM Pollock The Lancet 320 (8302), 781-784, 1982	852	1982
Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases G Enders, I Bolley, E Miller, J Cradock-Watson, M Ridehalgh The Lancet 343 (8912), 1548-1551, 1994	841	1994
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study E Miller, NJ Andrews, PA Waight, MPE Slack, RC George The Lancet infectious diseases 11 (10), 760-768, 2011	768	2011
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction CL Trotter, NJ Andrews, EB Kaczmarski, E Miller, ME Ramsay The Lancet 364 (9431), 365-367, 2004	753	2004
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study PA Waight, NJ Andrews, SN Ladhani, CL Sheppard, MPE Slack, E Miller The Lancet infectious diseases 15 (5), 535-543, 2015	701	2015
Population‐based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40 WA Knowles, P Pipkin, N Andrews, A Vyse, P Minor, DWG Brown, E Miller Journal of medical virology 71 (1), 115-123, 2003	676	2003
Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story E Miller, D Salisbury, M Ramsay Vaccine 20, S58-S67, 2001	618	2001
Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study NJ Andrews, PA Waight, P Burbidge, E Pearce, L Roalfe, M Zancolli, ... The Lancet infectious diseases 14 (9), 839-846, 2014	580	2014
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study SN Ladhani, S Collins, A Djennad, CL Sheppard, R Borrow, NK Fry, ... The Lancet Infectious Diseases 18 (4), 441-451, 2018	564	2018
Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis ME Ramsay, NJ Andrews, CL Trotter, EB Kaczmarski, E Miller Bmj 326 (7385), 365-366, 2003	545	2003
Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study B Taylor, E Miller, R Lingam, N Andrews, A Simmons, J Stowe Bmj 324 (7334), 393-396, 2002	489	2002
Patient risk factors for adverse drug events in hospitalized patients DW Bates, EB Miller, DJ Cullen, L Burdick, L Williams, N Laird, ... Archives of internal medicine 159 (21), 2553-2560, 1999	481	1999
Meningococcal surrogates of protection—serum bactericidal antibody activity R Borrow, P Balmer, E Miller Vaccine 23 (17-18), 2222-2227, 2005	479	2005
Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England ME Ramsay, N Andrews, EB Kaczmarski, E Miller The lancet 357 (9251), 195-196, 2001	453	2001
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines P Farrington, M Rush, E Miller, S Pugh, A Colville, A Flower, J Nash, ... The Lancet 345 (8949), 567-569, 1995	430	1995
Immediate and long term outcome of human parvovirus B19 infection in pregnancy E Miller, CK Fairley, BJ Cohen, C Seng BJOG: An International Journal of Obstetrics & Gynaecology 105 (2), 174-178, 1998	382	1998

Sistem trenutno ne more izvesti postopka. Poskusite znova pozneje.

Članki 1–20

Št. navedb na leto

Podvojene navedbe

Združene navedbe

Dodajanje soavtorjevSoavtorji

Spremljaj

Navedeno

Soavtorji